Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

ADIR investigates COX-2 inhibitors

Nov. 1, 1996

Key lupus patent issued to Genelabs

Oct. 25, 1996

AM-425 available for licensing

Oct. 25, 1996

PRIMATIZED monoclonal antibody proven safe and effective for rheumatoid arthritis

Oct. 25, 1996

Sulfasalazine approved for rheumatoid arthritis

Oct. 25, 1996

NIH seeks licensees for antigenic MMP peptides with potential as therapeutic and diagnostic agents

Oct. 25, 1996

MMP/TNF production inhibitors reported by Pfizer

Oct. 25, 1996

Dimethaid seeks approval for treatment for arthritic pain

Oct. 18, 1996

Washington University's MCP regulates complement activity

Oct. 18, 1996

New cPLA2 inhibitor from Merckle

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.